Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HDR”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT02258087
What this trial is testing

HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer.

Who this might be right for
Adenocarcinoma of Prostate
National Institute of Oncology, Hungary 50
Testing effectiveness (Phase 2)Study completedNCT04123366
What this trial is testing

Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)

Who this might be right for
Solid Tumors
Merck Sharp & Dohme LLC 333
Not applicableLooking for participantsNCT06863090
What this trial is testing

In Vivo Dosimetry for Brachytherapy Study

Who this might be right for
Prostate CancerGynaecological Cancer
East and North Hertfordshire NHS Trust 20
Large-scale testing (Phase 3)Study completedNCT01554397
What this trial is testing

Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer

Who this might be right for
Cervical Cancer
University of California, San Diego 101
Not applicableActive Not RecruitingNCT03426748
What this trial is testing

LDR vs. HDR Brachytherapy for Prostate Cancer

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 140
Testing effectiveness (Phase 2)Study completedNCT04240106
What this trial is testing

Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN)

Who this might be right for
Breast CancerBreast Cancer Metastatic
MedSIR 14
Large-scale testing (Phase 3)Study completedNCT01474356
What this trial is testing

Hyperthermia Combined Brachytherapy in CCU

Who this might be right for
Cervical Cancer
Maria Sklodowska-Curie National Research Institute of Oncology 224
Early research (Phase 1)Ended earlyNCT03924245
What this trial is testing

Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers

Who this might be right for
Fallopian Tube CancerFallopian Tube CarcinosarcomaFallopian Tube Clear Cell Adenocarcinoma+10 more
Vanderbilt-Ingram Cancer Center 3
Not applicableLooking for participantsNCT06432478
What this trial is testing

3D Printed Custom Applicators for HDR BT (DISCO)

Who this might be right for
Gynecologic CancerEndometrial CancerVaginal Cancer+1 more
Royal North Shore Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT04954599
What this trial is testing

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Maastricht University Medical Center 126
Testing effectiveness (Phase 2)Looking for participantsNCT07446855
What this trial is testing

Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours

Who this might be right for
Solid Tumours
AstraZeneca 180
Testing effectiveness (Phase 2)Study completedNCT03274661
What this trial is testing

Pembrolizumab Activity in Patients With Homologous Recombination Competent and Deficient Tumors

Who this might be right for
Solid Tumor, Adult
Baptist Health South Florida 52
Large-scale testing (Phase 3)Study completedNCT02765919
What this trial is testing

A Randomised Controlled Trial Between Two Different HDR Brachytherapy Schedule in Locally Advanced Carcinoma of Uterine Cervix

Who this might be right for
Squamous Cell Carcinoma of Cervix
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04053322
What this trial is testing

Durvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients.

Who this might be right for
ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancera Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status
UNICANCER 172
Testing effectiveness (Phase 2)Ended earlyNCT00214149
What this trial is testing

Multi-catheter High Dose Rate (HDR) Breast Brachytherapy

Who this might be right for
Breast Cancer
University of Wisconsin, Madison 127
Testing effectiveness (Phase 2)Active Not RecruitingNCT04465500
What this trial is testing

EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
University of Virginia 60
Testing effectiveness (Phase 2)UnknownNCT02283346
What this trial is testing

Single Fraction HDR Brachytherapy Plus Hypofractionated EBRT for Low-risk Prostate Cancer: Phase II Trial

Who this might be right for
Prostatic Neoplasms
AC Camargo Cancer Center 60
Not applicableStudy completedNCT01851772
What this trial is testing

Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer

Who this might be right for
Cervical Cancer
Xoft, Inc. 3
Not applicableLooking for participantsNCT06240559
What this trial is testing

In Vivo Treatment Verification of Brachytherapy

Who this might be right for
Brachytherapy
Maastricht Radiation Oncology 100
Not applicableActive Not RecruitingNCT02560181
What this trial is testing

Pilot Study of Whole Gland Salvage HDR Prostate Brachytherapy for Locally Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer Recurrent
Sunnybrook Health Sciences Centre 30
Next Page